EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL
Back
Abstract Number
WCN23-0069
Categories
AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Clinical Glomerulonephritis
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL
Co-authors
Kim , D.(1,2)*;Lv , J.(3);Hladunewich , M.(4);Jha , V.(5,6,7);Hooi , L.S.(8);Monaghan , H.(1);Billot , L.(1);Zhang , H.(3);Perkovic , V.(1);Wong , M.G.(1,2,9)
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)The George Institute For Global Health, University Of New South Wales, Sydney, Australia;(2)The University Of Sydney, Faculty Of Medicine And Health, Sydney, Australia;(3)Peking University First Hospital, Renal Division- Department Of Medicine, Beijing, China;(4)University Of Toronto, Sunnybrook Health Sciences Centre, Toronto, Canada;(5)The George Institute For Global Health India, University Of New South Wales, New Delhi, India;(6)The George Institute For Global Health, School Of Public Health- Imperial College, London, United Kingdom;(7)Manipal Academy Of Higher Education, Prasanna School Of Public Health, Manipal, India;(8)Sultanah Aminah Hospital, Renal Medicine, Johor Bahru, Malaysia;(9)Concord Repatriation General Hospital, Department Of Renal Medicine, Sydney, Australia
E-Poster
https://storage.unitedwebnetwork.com/files/1041/be4c07de5bfcfe8995989aa45a381917.pdf
Audio File
if any